Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
23.84
-3.81 (-13.78%)
Mar 31, 2025, 1:43 PM EDT - Market open

Biohaven Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
89.2462.77130.8637.4116.05
Research & Development
784.97373.28437.07181.4998.46
Operating Expenses
874.21436.05567.93218.9114.51
Operating Income
-874.21-436.05-567.93-218.9-114.51
Earnings From Equity Investments
---5.26-4.16
Other Non Operating Income (Expenses)
18.098.81-5.121.21-
EBT Excluding Unusual Items
-856.12-427.24-573.05-212.43-118.67
Gain (Loss) on Sale of Investments
21.3317.693.21--
Other Unusual Items
-10.9----
Pretax Income
-845.69-409.55-569.84-212.43-118.67
Income Tax Expense
0.74-1.380.441.37-
Net Income
-846.42-408.17-570.28-213.8-118.67
Net Income to Common
-846.42-408.17-570.28-213.8-118.67
Shares Outstanding (Basic)
9171453939
Shares Outstanding (Diluted)
9171453939
Shares Change (YoY)
28.14%59.14%13.63%--
EPS (Basic)
-9.28-5.73-12.75-5.43-3.01
EPS (Diluted)
-9.28-5.73-12.75-5.43-3.01
Free Cash Flow
-586.5-334.77-303.76-146.78-78.65
Free Cash Flow Per Share
-6.43-4.70-6.79-3.73-2.00
EBITDA
-866.36-429.14-566.55-217.51-114.43
D&A For EBITDA
7.866.911.391.390.07
EBIT
-874.21-436.05-567.93-218.9-114.51
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q